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abstRact
IntroductIon: Robotic-assisted laparoscopic hysterec-
tomy (RALH) has become a widely used approach for wom-
en with endometrial cancer and has replaced laparotomy.  
It has been questioned if the increased costs are justified by 
superior surgical outcomes. The aim of the present study 
was to examine the frequency, types and severity of post-
operative complications after total abdominal hysterectomy 
(TAH) and RALH using the Clavien-Dindo classification of 
surgical outcomes. 
Methods: A non-randomised, controlled before and after 
study of 360 women was conducted; 202 underwent RALH 
and 158 TAH (historical controls). 
results: RALH had significant advantages compared with 
TAH: fewer and less severe post-operative complications 
and a shorter length of hospital stay. The absolute risk re-
duction for post-operative complications was 13% (95% 
confidence interval: 4.29-20.87%). Women treated with 
TAH had significantly more severe complications (grade ≥ 3) 
than those treated with RALH; 12% versus 3% (p = 0.001). 
Infections (urinary and port site) were the most frequent 
post-operative complications overall. The duration of RALH 
in the operation theatre was longer, while the duration of 
stay in the post-anaesthesia care unit was shorter for pa-
tients undergoing RALH. 
conclusIons: RALH appears advantageous for women 
treated for endometrial cancer in terms of post-operative 
complications. We recommend the use of the Clavien-Dindo 
classification of surgical outcomes for quality assessment. 
FundIng: departmental only.
trIal regIstratIon: Danish Health Authority (3-2013-
111/1/KAHO).
 
Endometrial cancer is the most common cancer in the 
female genital tract in the developed world with an in-
cidence of 11-14 per 100,000 in Europe [1]. In high- 
income countries, a sedentary lifestyle and the obesity 
epidemic play a major role in the rising incidence [2].  
Endometrial cancer is most frequently detected in elder-
ly post-menopausal women with multiple comorbidities. 
Treatment for endometrial cancer is hysterectomy 
(HYS) and bilateral salpingo-oophorectomy (BSO). 
Lymph node involvement is an important prognostic fac-
tor [3]. In Denmark, cases with more than 50% myoinva-
sion or high-risk histology are offered pelvic lymphad-
enectomy (PLA). Danish guidelines recommend that 
atypical complex hyperplasia (ACH) be treated as endo-
metrial cancer.  
Previously, the standard procedure for HYS was lap-
arotomy. Nevertheless, HYS by laparoscopy has not 
been widely used in gynaecologic oncology. The limita-
tions of laparoscopy include counterintuitive motion, 
non-wristed instrumentation which contributes to a dif-
ficult and long learning curve [4]. Since 2005 when the 
US Food and Drug Administration approved robotic- 
assisted laparoscopy for use in gynaecology, there has 
been a rapid dissemination of this technique. The ro-
botic technique brings the advantages of minimally inva-
sive surgery: less post-operative morbidity and earlier 
recovery. Robotic-assisted surgery also has the specific 
advantages of 3-D-vision, higher magnification, better 
ergonomic conditions for surgeons and a shorter learn-
ing curve than for conventional laparoscopy. The disad-
vantages are lack of tactile feedback and high costs. In 
Denmark during the 2013-2014-period, more than 50% 
of women with endometrial cancer or ACH were treated 
by robotic-assisted laparoscopic hysterectomy (RALH), 
approximately 21% by laparotomy and 22% by laparos-
copy [5]. At our centre, however, laparoscopy has not 
been used for this indication. 
We lack evidence from randomised clinical trials 
(RCTs) comparing RALH with conventional open HYS in 
regard to post-operative complications. However, given 
the widespread adoption of RALH in clinical settings and 
patients’ preferences, it is probably no longer feasible to 
conduct randomised clinical trials. Nevertheless, in light 
of the increasing economic burden on our healthcare 
systems, the question persists whether the greater ex-
penses associated with robotic surgery are justified by 
superior surgical outcomes [6]. Some studies have pre-
sented their initial experiences with RALH [7] and con-
firm that robotic surgery has a short learning curve. For 
this reason, we wanted to compare the outcomes of 
RALH, excluding learning cases. This controlled before 
and after study aimed to examine the outcomes of total 
abdominal hysterectomy (TAH) by laparotomy versus ro-
botic-assisted HYS – both as implemented standard pro-
cedures. The primary outcome was the frequency, types 
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and severity of post-operative complications in women 
treated by HYS for endometrial cancer or ACH.
mEthOds
Consecutive patients undergoing RALH were compared 
with consecutive patients undergoing TAH (historical 
controls). The primary outcome was the frequency of 
patients developing one or more post-operative compli-
cations requiring treatment. The secondary outcomes 
were the type and severity of post-operative compli-
cation according to the Clavien-Dindo classification of 
surgical outcomes [8], length of hospital stay (LOS),  
dur ation of surgery (skin-to-skin time), duration of an-
aesthesia, and duration of stay in the post-anaesthetic 
care unit (PACU). The inclusion criteria were: women di-
agnosed with endometrial cancer or ACH treated with 
HYS by TAH (1 March 2006-1 March 2009) or by RALH  
(1 January 2013-1 September 2014). The follow-up time 
was four months. We defined post-operative complica-
tions as infections requiring antibiotic treatment within 
30 days, circulatory complications and abdominal com-
plications requiring treatment within 30 days. Further-
more, we monitored the occurrence of hernia, vaginal 
cuff dehiscence and lymfocele up to four months post-
operatively as these complications are surgically related 
but may take longer time to develop. We graded the se-
verity of post-operative complications according to the 
Clavien-Dindo classification of surgical outcomes [8]. We 
defined severe complications as complications of grade 
3 or higher [9].
Previous studies report complication rates in the 
6-12% range for women treated by RALH and 20-30% for 
women treated by TAH [7, 10]. With a minimally rele-
vant difference of 10% points in the frequency of pa-
tients developing post-operative complications requiring 
treatment, α = 5% and ß = 20%, power calculations indi-
cated that 141 women were required in each group.  
We used descriptive statistics with means and standard 
deviations as appropriate for continuous data and fre-
quencies and percentages for categorical data. To deter-
mine differences between groups, Fisher’s exact test 
was used for categorical variables and independent sam-
ples t-tests for continuous variables. We determined 
odds ratios (OR) by using binary logistic regression pre-
sented with and without adjustments for potential con-
founders. When there was a low number of events in 
the adjusted analysis, we only included potential con-
founders with a univariate p-value < 0.2 in addition to 
variables that were unbalanced at baseline. All calcu-
lated p-values were two-sided, and < 0.05 was con-
sidered statistically significant. To correct for mass sig-
nificance, we used Bonferroni correction for test on 
post-operative outcomes. We analysed data using SPSS 
version 19.9 (Inc., Chicago, Il, USA). 
abbREviatiOns
ACH = atypical complex hyperplasia
BSO = bilateral salpingo-oophorectomy
EBL = estimated blood loss
HYS = hysterectomy
LOS = length of stay
OM = omentectomy
OR = odds ratios 
PACU = post-anaesthetic care unit
PLA = pelvic lymphadenectomy
RCT = randomised controlled trial
RALH = robotic-assisted laparoscopic hysterectomy
TAH = total abdominal hysterectomy 
tablE 1
Baseline characteristics (N = 360).
type of hysterectomy
total abdominal  
(n1 = 158)
robotic-assisted  
laparoscopic (n2 = 202) p-value
Diagnosis, n (%)
Endometrial cancer 150 (95) 165 (82) < 0.001a
Atypical complex hyperplasia     8 (5)   37 (18)
Age, mean (± SD), yrs 68.5 (10.8) 68 (11.3) 0.66b
Body mass index
Mean (± SD), kg/m2 27.7 (7.4) 28.5 (7.1) 0.36b
Obese ≥ 30 kg/m2, n (%) 51 (32) 75 (37) 0.34a
Daily smoker, n (%) 20 (13) 23 (11) 0.74b
> 7 units alcohol/week, n (%) 17 (11) 49 (24) 0.002a
ASA-score, n (%) 0.09a
I & II 138 (87) 167 (83)
III   17 (11)   35 (17)
Missing     3 (2) –
Cardiovascular diseasec, n (%) 78 (49) 99 (49) 1.0a
Respiratory diseased, n (%) 7 (4) 15 (7) 0.27a
Diabetes Type II, n (%) 20 (13) 21 (10) 0.51a
ASA = American Society of Anesthesiologists; SD = standard deviation. 
a) Fisher’s exact test. 
b) Independent samples t-test. 
c) Hypertension, atrial fibrillation, arteriosclerotic heart disease, heart failure New York Heart Associ-
ation Classification of Heart Failure: 1) cardiac disease, but no symptoms and no limitation in ordinary 
physical activity, e.g. shortness of breath when walking, climbing stairs etc. 2) mild symptoms (mild 
shortness of breath and/or angina) and slight limitation during ordinary activity. 
d) Chronic obstructive pulmonary disease, asthma, emphysema.
Robotic-assisted lap -
aroscopy at Herlev and 
Gentofte Hospital.
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We have reported the study according to the 
STROBE statement for observational studies [11]. The 
National Council for Data Protection gave permission to 
file data (2207-58-015/HEH.750.16-27). The Danish 
Health Authority (3-2013-111/1/KAHO) and the head of 
the department of gynaecology Herlev and Gentofte 
Hospital, approved the acquisition of data from patient 
charts and hospital records. 
Trial registration: Danish Health Authority (3-2013-
111/1/KAHO).
REsUlts
We included 360 women, 158 had TAH and 202 had 
RALH. Age, BMI, smoking, ASA score and comorbidity did 
not differ between the groups (table 1). More women 
had ACH and more women exceeded seven units of al-
cohol per week in the RALH group. Women treated by 
RALH had a significantly lower estimated blood loss 
(EBL), longer skin-to-skin time, longer duration of anaes-
thesia, shorter duration of stay in the PACU and shorter 
LOS than women treated by TAH (table 2). In all three-
time measurements, a significant difference was found 
between TAH and RALH (Figure 1).
Women in the TAH group had a significantly higher 
frequency of one or more post-operative complications 
than the RALH group, 26% versus 13% (p = 0.003). The 
absolute risk reduction was 13% (95% confidence inter-
val (CI): 4.29-20.87%) (Table 2). With respect to the se-
verity of post-operative complications, women treated 
by TAH developed significantly more severe post-opera-
tive complications (grade ≥ 3) than those treated by 
RALH; 12% versus 3% (p = 0.001) (table 3). The adjusted 
OR for one or more post-operative complications in the 
RALH group was 0.39 (95% CI: 0.21-0.72) (p = 0.003). The 
adjusted OR for developing a Clavien-Dindo grade ≥ 3 
post-operative complication in the RALH group was 0.24 
(95% CI: 0.08-0.69) (p = 0.008).
3% in the TAH group developed intraoperative com-
plications (lesion of the bladder n = 1, lesion of the intes-
tine n = 2, and lesion of larger vessels n = 2) compared 
with 1% in the RALH group (lesion of the bladder n = 2). 
Infections (urinary and port site) were the most frequent 
post-operative complication overall. In each group, one 
woman had a stroke post-operatively and two deaths 
occurred. A 70-year-old woman developed vaginal hae-
matoma, pulmonary embolus and urosepsis and died 
three months after TAH. An 88-year-old woman devel-
oped urosepsis and ileus and died three weeks after 
RALH with conversion to open surgery. 
In the TAH group, 85 (54%) had HYS and BSO as op-
posed to 153 (76%) in the RALH group. In the TAH group, 
73 (46%) had HYS, BSO, PLA and/or omentectomy (OM) 
as opposed to 49 (24%) in the RALH group (p < 0.001). 
The mean number of lymph nodes resected was 20 in 
both groups; in the RALH group, conversion to TAH oc-
curred in four (2%) women.
Subgroup analysis excluding women who had more 
extensive surgery (PLA and/or OM) (n = 238) did not 
change the overall results, but showed 26% with post-
operative complications in the TAH group versus 13% in 
the RALH group (p = 0.02). Using the Clavien-Dindo clas-
sification of surgical outcomes, the corresponding fig-
ures were 12% in the TAH group with post-operative 
complications grade ≥ 3 versus 3% in the RALH group  
(p = 0.007). However, when we analysed only women 
with HYS + BSO and PLA and/or OM (n = 122), the fre-
quency of post-operative complications between the 
groups did not differ significantly; 26% in the TAH group 
versus 14% in the RALH group (p = 0.18). Likewise, the 
frequency of post-operative complications of grade ≥ 3 
according to the Clavien-Dindo classification did not dif-
fer significantly; 12% in the TAH group versus 4% in the 
RALH group (p = 0.2).
tablE 2
Findings and complications (N = 360).
type of hysterectomy
total abdominal  
(n1 = 158)
robotic-assisted  
laparoscopic (n2 = 202) p-value
Intraoperative
Intraoperative bleeding, mean (± SD), ml 299 (± 275) 41 (± 58) < 0.001b, c
Skin-to-skin timea, mean (± SD), min. 102 (± 34) 120 (± 46) < 0.001b, c
Anaesthesia timea, mean (± SD), min. 180 (± 62) 221 (± 70) < 0.001b, c
PACU timea, mean (± SD), min. 455 (± 221) 186 (± 119) < 0.001b, c
Post-operative
Length of stay, mean (± SD), days 6 (± 3.5) 3 (± 1.8) < 0.001b, c
Readmission within 30 days, n (%) 16 (10) 15 (7) 0.45d
Reoperation within 30 days, n (%) 11 (7) 6 (3) 0.09d
Complications, n (%)
Infections within 30 dayse 27 (17) 22 (11) –
Abdominal complications within 30 daysf   9 (6) 6 (3) –
Circulatory complications within 30 daysg   9 (6) 2 (1) –
Long-term surgically related within 4 mo.sh   6 (4) 2 (1) –
Frequency of post-operative complication
≥ 1 complicationsi, j, n (%) 41 (26) 27 (13) 0.003c, d
PACU = post-anaesthetic care unit; SD = standard deviation. 
a) For detailed time measurements for subgroups see Figure 1. 
b) Independent samples t-test. 
c) Also significant after Bonferroni correction for mass significance (α = 0.005/8 = 0.000625). 
d) Fisher’s exact test. 
e) Port site/wound infection, intraabdominal infection, infection with unknown focus, vaginal cuff infec-
tion, urinary tract infection, pneumonia, sepsis, gastroenteritis. 
f) Wound rupture, intraabdominal bleeding, ulcer/gastritis, vesico-vaginal fistula, ileus. 
g) Pulmonary oedema, myocardial infarction, pulmonary embolism, deep vein thrombosis, stroke. 
h) Vaginal cuff dehiscence, hernia, lymfocele. 
i) 6 women had 2, and 2 women had 3 post-operative complications in the TAH group; 3 women had 2, 
and 1 had 3 post-operative complications in the RALH group. 
j) Absolute risk reduction: 26–13 = 13 (95% confidence interval: 4.29-20.87) %-points.
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discUssiOn 
In this study, women in the RALH group developed  
fewer and less severe post-operative complications than 
those undergoing TAH. Complications in the RALH group 
were primarily infections. Diabetes, obesity and high age 
can increase the risk of infections and are all predomin-
ant risk factors in women with endometrial cancer [3]. 
The observed 3% frequency of grade 3 or higher post-
operative complications according to the Clavien-Dindo 
classification of surgical outcomes in the RALH group 
may be considered quite low for this type of surgery. 
The frequency observed here is similar to that observed 
in women undergoing robotic HYS for benign indications 
(2.4-3.1%) [9, 12]. These studies also used the Clavien-
Dindo classification of surgical outcomes to assess com-
plications, which enables direct comparison across 
popu lations and centres. The RALH group had a lower 
EBL and a shorter LOS. A reduced EBL is desirable as it 
decreases the post-operative recovery time for patients. 
Compared with laparotomy, a shorter LOS is a well-
known positive outcome of minimally invasive surgery, 
for patients and health costs alike [13].
At baseline, more women in the RALH group ex-
ceeded seven units of alcohol per week. Adjustment for 
this baseline difference in alcohol consumption did not 
change the significantly decreased risk of developing 
one or more complications in the RALH group. 
The data in this study did not reflect a RALH learn-
ing period for surgeons. However, skin-to-skin time and 
duration of anaesthesia in the RALH group were signifi-
cantly longer than in the TAH group, which concurs with 
findings reported by other studies [14]. The mean differ-
ence in skin-to-skin time was 18 minutes in favour of 
TAH in our study. Our mean skin-to-skin time in the ro-
botic group (120 minutes) is close to the findings re-
ported from studies of women treated with HYS for be-
nign indication (105 minutes) [9]. In the present study, 
the mean skin-to-skin time was 173 minutes for HYS + 
SBO and PLA and/or OM by RALH. Previous studies of 
HYS, BSO and lymphadenectomy for endometrial cancer 
reported longer mean skin-to-skin times (189-191 min-
utes) [10, 15], whereas others reported shorter skin-to 
skin times (127 minutes) [16, 17]. As robotic surgery be-
comes more and more routine, skin-to-skin time is likely 
to be minimised. For example, recent studies of open 
versus robotic surgery for endometrial cancer showed a 
significant difference in skin-to-skin time in favour of the 
robotic group [16, 17]. 
Some of the changes in LOS and duration of stay in 
the PACU seen in this study across the two time periods 
may be due to an increased turnover in the PACU and in 
hospitals in general. At baseline, we found a difference 
in the number of women who had PLA and/or OM per-
formed in the two groups. A reason for this could be 
that recent years have seen further centralisation of the 
treatment of gynaecologic cancer in Denmark resulting 
in more women with ACH being treated at specialised 
centres. Subgroup analysis excluding women undergoing 
more extensive surgery did not change the significant 
reduction in the frequency or severity of complications 
in favour of RALH. 
Apart from the patient advantages and better ergo-
nomics for surgeons, it has been suggested that robotic 
surgery is superior especially when operating morbidly 
FigURE 1
Mean time measures in 
minutes*.
BSO = bilateral salpingo-
oophorectomy;  
HYS = hysterectomy;  
PACU = post-anaesthetic 
care unit; PLA/OM =  
pelvic lymphadenectomy 
and/or omentectomy; 
RALH = robotic-assisted 
laparoscopic hysterec-
tomy; TAH = total ab-
dominal hysterectomy.
*) Significant differences 
between the RALH and 
the TAH groups for HYS + 
BSO and for HYS + BSO 
and PLA/OM measured 
for all three-time meas-
ures by independent  
samples t-tests.
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tablE 3
Severity of complications according to the Clavien-Dindo classification of 
surgical outcomesa. The values are n (%).
type of hysterectomy
grade
total abdominal  
(n = 158)
robotic-assisted lapa-
roscopic (n = 202) p-value
1   5 (3) 14 (7)
2 32 (20) 28 (14)
≥ 3
3a   3 (2)   0
3b 14 (9)   5 (3)
4a   2 (1)   0
4b   0   0
5   0   1 (< 1)
Sub-totalb 19 (12)   6 (3) 0.001c
a) Severe complications are defined as complications of grade ≥ 3 (for 
the definition of  grades, see [8]). 
b) Absolute risk reduction: 12-3 = 9 (95% confidence interval: 3.7-15.3) 
%-points. 
c) Fisher’s exact test.
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obese patients. It is considered better to sit in a console 
and be able to adjust the height of the stereoscopic 
viewer, the arm rest and the position of the pedals to 
accommodate the operating surgeon’s body length than 
to stand at the operating table. However, a recent on-
line survey study of 432 robotic surgeons working in 
general surgery, gynaecology and in urology showed 
that 56% of surgeons experienced physical symptoms or 
discomfort [18]. The most frequent symptoms were 
neck and finger stiffness and eye fatigue [18], suggesting 
that the new surgical work position might produce new 
ergonomic problems while diminishing others.  
A strength of this study is the exclusion of learning 
cases. We used the validated Clavien-Dindo classification 
of surgical outcomes, which enables comparison across 
populations owing to its widespread use in surgical  
studies. This was an observational “controlled before 
and after study” and a limitation of this design is the risk 
of confounding leading to biased estimates of treatment 
effects [19]. Effects of different interventions are prefer-
ably evaluated in RCTs. However, we considered that an 
observational design was the only feasible option within 
the field of gynaecologic robotic surgery given the cur-
rent widespread adoption of robotic surgery as standard 
treatment. 
Further limitations of this study include the use of 
historical controls and retrospective collection of data. 
We sought to address the latter by using the Clavien-
Dindo classification of surgical outcomes, which is par-
ticularly relevant in retrospective analyses as it identifies 
complications specifically from the documentation of 
therapy to treat a complication rather than from docu-
mentation of the complications [20]. RALH had advan-
tages compared with TAH in women with endometrial 
cancer and atypical complex hyperplasia, including sig-
nificantly fewer and less severe complications, less 
bleeding and a shorter LOS than TAH. Robotic surgery 
takes longer in the operating theatre, but shortens the 
duration of stay in the PACU. 
cORREspOndEncE: Suzanne Forsyth Herling.  
E-mail: suzanne.herling@gmail.com
accEptEd: 6 January 2017
cOnFlicts OF intEREst: Disclosure forms provided by the authors are 
available with the full text of this article at www.danmedj.dk
acknOwlEdgEmEnts: The authors would like to extend their gratitude to 
Jens Jacob Krintel and Bjørn Dreijer for assisting with the retrieval of data and 
to Tobias W. Clausen for statistical guidance.
litERatURE
1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: 
the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-
25.
2. Amant F, Mirza MR, Creutzberg CL. Cancer of the corpus uteri. Int J 
Gynaecol Obstet 2012;119(suppl):S110-S117.
3. Saso S, Chatterjee J, Georgiou E. Endometrial cancer. BMJ 2011;343: 
d3954.
4. Seamon LG, Cohn DE, Henretta MS et al. Minimally invasive compre-
hensive surgical staging for endometrial cancer: Robotics or laparoscopy? 
Gynecol Oncol 2009;113:36-41.
5. DGCG. Dansk Gynækologisk Cancer Database Landsdækkende klinisk 
database for kræft i æggestokke, livmoder og livmoderhals. 2014. www.
sundhed.dk/content/cms/80/4680_årsrapport_dgcd_2013-14_endelig-
version.pdf (23 Jan 2017).
6. Weissman JS, Zinner M. Comparative effectiveness research on robotic 
surgery. JAMA 2013;309:721-2. 
7. Veljovich DS, Paley PJ, Drescher CW et al. Robotic surgery in gynecologic 
oncology: program initiation and outcomes after the first year with 
comparison with laparotomy for endometrial cancer staging. Am J Obstet 
Gynecol 2008;198:679.e1-e9; discussion 679.e9-e10.
8. Dindo D, Demartines N, Clavien P-A. Classification of surgical compli-
cations. Ann Surg 2004;240:205-13. 
9. Wechter ME, Mohd J, Magrina JF et al. Complications in robotic-assisted 
gynecologic surgery according to case type: a 6-year retrospective cohort 
study using Clavien-Dindo classification. J Minim Invasive Gynecol 2014; 
21:844-50. 
10. Boggess JF, Gehrig PA, Cantrell L et al. A comparative study of 3 surgical 
methods for hysterectomy with staging for endometrial cancer: robotic 
assistance, laparoscopy, laparotomy. Am J Obstet Gynecol 2008;199:360.
e1-e9. 
11. Elm E von, Altman DG, Egger M et al. The Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) statement: guidelines for 
reporting observational studies. Lancet 2007;370:1453-7. 
12. Patzkowsky KE, As-Sanie S, Smorgick N et al. Perioperative outcomes of 
robotic versus laparoscopic hysterectomy for benign disease. JSLS 2013; 
17:100-6. 
13. Bell MC, Torgerson JA, Seshadri-Kreaden U et al. Comparison of outcomes 
and cost for endometrial cancer staging via traditional laparotomy, stan-
dard laparoscopy and robotic techniques. Gynecol Oncol 2008;111:407-
11. 
14. Gala RB, Margulies R, Steinberg A et al. Systematic review of robotic 
surgery in gynecology: robotic techniques compared with laparoscopy and 
laparotomy. J Minim Invasive Gynecol 2014;21:353-61. 
15. Magrina JF, Kho RM, Weaver AL et al. Robotic radical hysterectomy: 
comparison with laparoscopy and laparotomy. Gynecol Oncol 2008; 
109:86-91. 
16. Eklind S, Lindfors A, Sjöli P et al. A prospective, comparative study on 
robotic versus open-surgery hysterectomy and pelvic lymphadenectomy 
for endometrial carcinoma. Int J Gynecol Cancer 2015;25:250-6.
17. ElSahwi KS, Hooper C, De Leon MC et al. Comparison between 155 cases 
of robotic vs. 150 cases of open surgical staging for endometrial cancer. 
Gynecol Oncol 2012;124:260-4. 
18. Lee GI, Lee MR, Green I et al. Surgeons’ physical discomfort and symptoms 
during robotic surgery: a comprehensive ergonomic survey study. Surg 
Endosc 11 Aug 2016 (e-pub ahead of print). 
19. Kao LS, Tyson JE, Blakely ML et al. Clinical research methodology I: 
Introduction to randomized trials. J Am Coll Surg 2008;206:361-9. 
20. Clavien PA, Barkun J, de Oliveira ML et al. The Clavien-Dindo classification 
of surgical complications: five-year experience. Ann Surg 2009;250:187-96.
